These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2530769)

  • 1. An overview of the animal pharmacology of paroxetine.
    Johnson AM
    Acta Psychiatr Scand Suppl; 1989; 350():14-20. PubMed ID: 2530769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor.
    Thomas DR; Nelson DR; Johnson AM
    Psychopharmacology (Berl); 1987; 93(2):193-200. PubMed ID: 2962217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specific inhibitory action of a novel antidepressant paroxetine on 5-HT uptake].
    Tanigaki N; Manno K; Sugihara K; Miki N; Ichida S; Yoshida H
    Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):175-80. PubMed ID: 3038714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological effects of paroxetine after repeated administration to animals.
    Nelson DR; Thomas DR; Johnson AM
    Acta Psychiatr Scand Suppl; 1989; 350():21-3. PubMed ID: 2530778
    [No Abstract]   [Full Text] [Related]  

  • 5. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat.
    Chaput Y; de Montigny C; Blier P
    Neuropsychopharmacology; 1991 Dec; 5(4):219-29. PubMed ID: 1839498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
    Dechant KL; Clissold SP
    Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavioral pharmacological properties of the novel antidepressant paroxetine, a selective 5-HT uptake inhibitor].
    Yamamoto T; Shibata S; Shimazoe T; Iwasaki K; Ohno M; Minamoto Y; Furuya Y; Miyamoto K; Watanabe S; Ueki S
    Nihon Yakurigaku Zasshi; 1989 Sep; 94(3):189-206. PubMed ID: 2530142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of some effects of paroxetine with amitriptyline on the cardiovascular system in animals.
    Hamilton TC; Norton J; Poyser RH; Thormählen D
    Arzneimittelforschung; 1986 Mar; 36(3):460-3. PubMed ID: 2939838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of paroxetine on the quantitative EEG.
    McClelland GR; Raptopoulos P; Jackson D
    Acta Psychiatr Scand Suppl; 1989; 350():50-2. PubMed ID: 2530790
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical pharmacology of paroxetine in healthy subjects.
    Raptopoulos P; McClelland GR; Jackson D
    Acta Psychiatr Scand Suppl; 1989; 350():46-8. PubMed ID: 2530788
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of prolonged 5-hydroxytryptamine uptake inhibition by paroxetine on cortical beta 1 and beta 2-adrenoceptors in rat brain.
    Nelson DR; Palmer KJ; Johnson AM
    Life Sci; 1990; 47(18):1683-91. PubMed ID: 1979137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and psychomotor effects of repeated doses of paroxetine: a comparison with amitriptyline and placebo in healthy men.
    Warrington SJ; Dana-Haeri J; Sinclair AJ
    Acta Psychiatr Scand Suppl; 1989; 350():42-4. PubMed ID: 2530786
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic pathway of paroxetine in animals and man and the comparative pharmacological properties of its metabolites.
    Haddock RE; Johnson AM; Langley PF; Nelson DR; Pope JA; Thomas DR; Woods FR
    Acta Psychiatr Scand Suppl; 1989; 350():24-6. PubMed ID: 2530779
    [No Abstract]   [Full Text] [Related]  

  • 14. Paroxetine: lack of effect on the tyramine pressor response in man.
    Hassan SM; Wainscott G; Turner P
    Acta Psychiatr Scand Suppl; 1989; 350():49. PubMed ID: 2530789
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of paroxetine and other antidepressants in combination with alcohol on psychomotor activity related to car driving.
    Hindmarch I; Harrison C
    Acta Psychiatr Scand Suppl; 1989; 350():45. PubMed ID: 2530787
    [No Abstract]   [Full Text] [Related]  

  • 16. Paroxetine, a selective 5-hydroxytryptamine uptake inhibitor with antidepressant properties, lacks amphetamine-like stimulus properties in an operant drug discrimination bioassay in rodents.
    Goudie AJ; Dubicki W; Leathley M
    J Pharm Pharmacol; 1988 Mar; 40(3):192-6. PubMed ID: 2899149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the selective 5-hydroxytryptamine uptake inhibitors paroxetine and zimeldine on EEG sleep and waking stages in the rat.
    Kleinlogel H; Burki HR
    Neuropsychobiology; 1987; 17(4):206-12. PubMed ID: 2964564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroencephalographic effects of the new antidepressant paroxetine in the rabbit.
    Watanabe S; Ohta H; Ohno M; Tani Y; Furuya Y; Ueki S; Man'no K; Sugihara K
    Arzneimittelforschung; 1988 Mar; 38(3):332-40. PubMed ID: 2968081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
    Galzin AM; Moret C; Verzier B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo labeling of serotonin uptake sites with [3H]paroxetine.
    Scheffel U; Hartig PR
    J Neurochem; 1989 May; 52(5):1605-12. PubMed ID: 2523469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.